ENG, endoglin, 2022

N. diseases: 371; N. variants: 114
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Familial primary pulmonary hypertension
0.520 GeneticVariation disease BEFREE Heritable pulmonary arterial hypertension (PAH) is an autosomal dominant disease with incomplete penetrance because of mutations in bone morphogenetic protein receptor-II (BMPR2), activin A receptor type II-like kinase 1, endoglin, caveolin-1, potassium channel subfamily K, member 3, and T-box gene 4 genes. 28661905 2017
Familial primary pulmonary hypertension
0.520 Biomarker disease GENOMICS_ENGLAND Genetic counselling in a national referral centre for pulmonary hypertension. 26699722 2016
Familial primary pulmonary hypertension
0.520 GeneticVariation disease ORPHANET The genetics of pulmonary arterial hypertension. 24951767 2014
Familial primary pulmonary hypertension
0.520 GeneticVariation disease BEFREE Five mutations in the bone morphogenetic protein type II receptor (BMPR2) gene, 2 Activin A receptor type II-like kinase-1 (ACVRL1) mutations and one Endoglin (ENG) mutation were found in the 29 I/HPAH children. 23298310 2013
Familial primary pulmonary hypertension
0.520 GeneticVariation disease ORPHANET Five mutations in the bone morphogenetic protein type II receptor (BMPR2) gene, 2 Activin A receptor type II-like kinase-1 (ACVRL1) mutations and one Endoglin (ENG) mutation were found in the 29 I/HPAH children. 23298310 2013
Familial primary pulmonary hypertension
0.520 GeneticVariation disease ORPHANET Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. 15687131 2005
Familial primary pulmonary hypertension
0.520 GeneticVariation disease ORPHANET Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. 15115879 2004